Matthew Korenberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Korenberg
Matthew Korenberg was last confirmed as Board Member at Lifecore Biomedical, Inc. \De\ (LFCR) in a filing dated September 23, 2024. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed August 21, 2024 that Matthew Korenberg was appointed director, effective August 15, 2024. Lifecore Biomedical, Inc. \De\ reported in an 8-K filed July 1, 2024 that Matthew Korenberg was appointed director.
“On August 15, 2024, in accordance with the terms of the cooperation agreements between the Company and certain stockholders of the Company, which were previously disclosed on that certain Current Report on Form 8-K filed by the Company on July 1, 2024 (the “Cooperation Agreements”), the Board appointed Jason Aryeh, Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors of the Board, effective immediately following the Annual Meeting.”
“On June 28, 2024, pursuant to the 22NW Cooperation Agreement, the Board, upon the recommendation of the Nominating Committee, appointed Paul H. Johnson, Humberto C. Antunes, and Matthew Korenberg as directors, effective immediately following the conclusion of the 2023 Annual Meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2024-08-15–2024-09-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.